Archives

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Tag: R&D

Career Change

6 Reasons Why Pharmaceutical Careers are Lucrative

Via: https://www.biospace.com/article/6-reasons-why-a-career-in-pharma-is-lucrative-/ Published: Feb 09, 2022 By Alina Zahid Pharmaceutical careers are increasing rapidly and here’s why you should be considering it for yourself  The pharmaceutical industry has grown at a rapid pace over the past few years. With new innovations and discoveries constantly being made,

Read More »
Life Sciences Expansions Take Off as 2021 Wraps Up

Life Sciences Expansions Take Off as 2021 Wraps Up

Via: https://www.biospace.com/article/life-science-companies-announce-expansion-plans-as-they-wrap-up-2021 Published: Dec 08, 2021 By Mark Terry Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end. Here’s a look: Novavax to Expand Maryland Campus Novavax, on the cusp of getting its COVID-19 vaccine

Read More »
6 Reasons to Decline a Counter Job Offer

6 Reasons to Decline a Counter Job Offer

Counteroffers often result when your employer suspects they may be losing a talented employee. They are all of a sudden hit with this reality – there’s something that another company sees in you. Once you’ve given your 2-weeks notice your employer decides you’re worth investing

Read More »

BioSpace Movers & Shakers, October 15th

Via: https://www.biospace.com/article/biospace-movers-shakers-oct-15/ Published: Oct 15, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and executive boards with these Movers & Shakers.  Reneo Pharmaceuticals – Ashley F. Hall was named chief development officer at California-based Reneo Pharmaceuticals. Hall will oversee nonclinical and clinical

Read More »
New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

Via: https://www.biospace.com/article/releases/new-study-finds-freenome-s-multiomics-approach-successful-in-detecting-pancreatic-cancer/ Published: Sep 29, 2021 SOUTH SAN FRANCISCO, Calif., Sept. 29, 2021 /PRNewswire/ — Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer Research (AACR) Special Conference on Pancreatic Cancer. The data demonstrated the potential of extending Freenome’s multiomics approach into other

Read More »